Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis. - Tsuchiya H; Ota M; Takahashi H; Hatano H; Ogawa M; Nakajima S; Yoshihara R; Okamura T; Sumitomo S; Fujio K (Inflammation and regeneration, 2024)